Researchers at Boston Children’s Hospital have developed an antibody capable of neutralizing all known SARS-CoV-2 variants in pre-clinical assessments, according to an August pre-print. The study published within Science Immunology, presents a potential solution to future variants of concern, as this is the first effective antibody that neutralizes all major variants through the recent Omicron BA.5 variant.
The U.S. Food and Drug Administrationgranted market authorization to an electronic cigarette company for the first time on Tuesday, approving certain products for sale in the United States. The FDAapproved three products from R.J. Reynolds Vapor Company’s brand, Vuse, in an effort to diminish the impacts of traditional cigarettes, whose carcinogenic properties contribute to an estimated 400,000 U.S. deaths each year. The FDA concluded that the reduced morbidity and mortality among smokers outweigh the risks that approving Vuse products poses to youth. Notably, 10% of high school students who use e-cigarettes said Vuse is their usual brand.
Melissa Ing (D’89), an associate professor at the Tufts University School of Dental Medicine, filed a lawsuit earlier this year accusing the university of gender discrimination and retaliation for complaining of alleged sexual harassment. Ing is currently awaiting trial by jury.
Becca Bell, a fourth-year medical student who recently matched at Dartmouth-Hitchcock Medical Center for otolaryngology, explained how TUSM’s Maine Track program guided her career choices. As part of the Maine program, Bell did her third and fourth years of medical school at Maine Medical Center.